期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

异噻唑酮取代的间苯二甲酸衍生物的设计、合成及其抑制β-分泌酶活性 被引量：2

Design,synthesis and inhibitory activity against β-secretase of isothiazolone substituted isophthalic acid derivatives
原文传递
导出
摘要 目的发现新结构的β-分泌酶抑制剂。方法基于对β-分泌酶与其典型的抑制剂结合位点的分析,辅以分子对接实验,设计并合成异噻唑酮取代的间苯二间羧酸衍生物;采用时间分辨荧光法(time-resolved fluo-rescence,TRF)检测化合物对β-分泌酶的抑制活性。结果合成了10个异噻唑酮取代的苯二羧酸衍生物,其结构经MS和1H-NMR确证,其纯度经HPLC测定;时间分辨荧光法(TRF)检测结果显示有4个化合物对β-分泌酶具有显著的抑制活性,其中化合物22a抑制β-分泌酶的IC50值为13.7nmo.lL-1。结论发现了新的β-分泌酶抑制剂,得出了初步的构效关系,为进一步的结构优化奠定了基础。 Aim To discover new structure of β-secretase inhibitors.Methods Combining with Dock method and basing on the structural feature of active site of β-secretase binding to the typical inhibitors,isothiazolone substituted isophthalic acid derivatives were designed and synthesized.Time-resolved fluorescence（TRF） was used to evaluate the inhibitory activity of these compounds against β-secretase.Results Ten target compounds were synthesized and their structures were identified by MS and 1H-NMR.The purity of these compounds was determined by HPLC.Binding assay（TRF） showed that four of these ten compounds had obvious inhibitory activity against β-secretase.Especially,the IC50 value of compound 22a against β-secretase was 13.7 nmol·L-1.Conclusion New type β-secretase inhibitors were discovered.The preliminary structure-activity relationship concluding from this research will give a direction for the structural optimization of these β-secretase inhibitors.
作者 高善云 顾为 程军平 程肖蕊 周文霞 聂爱华
机构地区 军事医学科学院毒物药物研究所
出处 《中国药物化学杂志》 CAS CSCD 2010年第6期467-475,共9页 Chinese Journal of Medicinal Chemistry
关键词 Β-分泌酶 抑制剂 设计 合成 β-secretase inhibitor design synthesis
分类号 R91 [医药卫生—药学]
  • 相关文献

参考文献15

  • 1HARDY J,HIGGINS G A. Alzheimer's diseases:the amyloid cascade hypothesis [ J]. Science, 1992,256 (5054) : 184 - 185.
  • 2SELKOE D J. Translating cell biology into therapeu- tic advances in Alzheimer' s diseases [ J ]. Nature, 1999,399(6738 Suppl) :A23 - A3t.
  • 3GHOSH A K,KUMARAGURUBARAN N, HONG L,et al. Design, synthesis, and X-ray structure of po- tent memapsin 2(β-secretase) inhibitors with isoph- thalamide derivatives as the P2-P3-ligands[ J]. J Med Chem,2007,50 (10) : 2399 - 2407.
  • 4YOSHIO H,YOSHIAKI K. Recent progress in the drug discovery of non-pepfidic BACE1 inhibitors[ J]. Expert Opin Drug Discov,2009,4(4) :391 -416.
  • 5GHOSH A K,SHIN D,DOWNS D,et al. Design of potent inhibitors for human brain memapsin 2 (beta- secretase) [ J ]. J Am Chem Soc, 2000, 122 ( 14 ) : 3522 - 3523.
  • 6HONG L,TURNER R T,KOELSCH G,et al. Crys- tal structure of memapsin 2(β-secretase) in complex with an inhibitor OM00-3 [ J ]. Biochemistry, 2002, 41 (36) : 10963 - 10967.
  • 7SHAWN J S, CRAIG A C, THOMAS G S, et al. Structure-based design of potent and selective cell- permeable inhibitors of human β-secretase( BACE-1 ) [J]. J Med them,2004,47(26) :6447 -6450.
  • 8CRAIG A C, SHAWN J S, KRISTEN G J, et al. BACE-1 inhibition by a series of ψ[CH2NH] re- duced amide isosteres [ J]. Bioorg Med Chem Lett, 2006,16(14) :3635 - 3638.
  • 9CHARRIER N, CLARKE B,CUTLER L,et al. Se- cond generation of hydroxyethylamine BACE-1 inhi- bitors: optimizing potency and oral bioavailability [ J]. J Med Chem ,2008 ,51 ( 11 ) :3313 -3317.
  • 10KORTUM S W,BENSON T E,BIENKOWSKI M J, et al. Potent and selective isophthalamide S2 hydroxy- ethylamine inhibitors of BACE1 [ J ]. Bioorg Med Chem Lett,2007,17 (12) :3378 - 3383.

同被引文献18

  • 1HARDY J A, HIGGINS G A. Alzheimer's disease: the amyloid cascade hypothesis [ J ]. Science, 1992, 256(5054) : 184 - 185.
  • 2SHANTA B, YONA L, MICHAEL R S. Inhibiting β- secretase activity in Alzheimer's disease cell models with single chain antibodies specifically targeting APP[ J]. J Mol Biol,2011,405(2) :436 -447.
  • 3COLE S L, VASSAR R. BACE1 structure and func- tion in health and Alzheimer' s disease [ J ]. Curr Alzheimer Res ,2008,5 (2) : 100 - 120.
  • 4ROBERDS S L, ANDERSON J, BASI G, et al. BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain:implications for Alzheimer's disease therapeutics[ J]. Hum Mol Gen- et,2001,10(12) : 1317 - 1324.
  • 5LUO Y, BOLON B, KAHN S, et al. Mice deficient in BACE1 ,the Alzheimer's β-secretase,have normal phenotype an dabolished β-amyloid generation [J ]. Nat Neurosci,2001,4 (3) :231 - 232.
  • 6BEAULIEU P L, WERNIC D. Preparation of amino- alkyl chlorohydrin hydrochlorides: key building blocks for hydroxyethylamines-based HIV protease inhibitors[ J]. J Org Chem, 1996,61 ( 11 ) :3635 - 3645.
  • 7NG J S, PRZYBYLA C A, LIU C, et al. A practical synthesis of an HIV protease inhibitor intermediate- diastereoselective epoxide formation from chiral α- aminoaldehydes [ J ]. Tetrahedron, 1995, 51 ( 23 ) : 6397 - 6410.
  • 8LEWIS S N, MILLER G A, HAUSMAN M. Isothia- zoles I: 4-isothiazolin-3-ones. A general synthesis from 3,3'-dithiodipropionamides [ J ]. J Heterocycl Chem,1971,8(4) :571 -580.
  • 9MARIA A A, MARCIAL M M, FERNANDO L, et al. Electrospray ionization mass spectrometry detec- tion of intermediates in the palladium-catalyzed oxi- dative self-coupling of areneboronic acids [ J ]. J Org Chem, 1999,64 (10) :3592 - 3594.
  • 10MARCIAL M M, MONTSERRAT P, ROSER P. Pal- ladium-catalyzed suzuki-type self-coupling of arylbo- ronic acids. A mechanistic study [ J ]. J Org Chem, 1996,61 (7) : 2346 - 2351.

引证文献2

二级引证文献2

中国药物化学杂志
2010年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部